Who owns BRIDGEBIO PHARMA INC?
- CUSIP Number: 10806xad4
Tip: Access positions for across all investors
Analyze quarterly positions in Bridgebio Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bridgebio Pharma stock
Who bought or sold BRIDGEBIO PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 214M | $241M | 22% | Dec 2025 |
|
| Wolverine Asset Management | 86M | $97M | 94% | Dec 2025 |
|
| Context Capital Management | 80M | $90M | 81403% | Dec 2025 |
|
| Ing Investment Management | 30M | $34M | 0% | Dec 2025 |
|
| MacKay Shields | 29M | $32M | -1% | Dec 2025 |
|
| D. E. Shaw & Co | 29M | $28M | 30% | Sep 2025 |
|
| CSS | 27M | $30M | 1667% | Dec 2025 |
|
| Polar Capital Holdings | 24M | $27M | 100% | Dec 2025 |
|
| Sona Asset Management | 22M | $25M | -30% | Dec 2025 |
|
| Advent Capital Management | 21M | $23M | -5% | Dec 2025 |
|
| Nuveen | 20M | $23M | 100% | Dec 2025 |
|
| Laurion Capital Management | 19M | $22M | 0% | Dec 2025 |
|
| State Street Corporation | 16M | $18M | 6% | Dec 2025 |
|
| Wells Fargo & Company | 15M | $17M | -35% | Dec 2025 |
|
| Oaktree Capital Management | 11M | $11M | -40% | Sep 2025 |
|
| Shenkman Capital Management | 11M | $12B | 59% | Dec 2025 |
|
| Davidson Kempner Capital Management | 10M | $11M | -67% | Dec 2025 |
|
| BlackRock | 9.5M | $11M | 32% | Dec 2025 |
|
| Silverback Asset Management | 9.5M | $9.3M | -27% | Sep 2025 |
|
| FMR | 8.7M | $8.5M | -5% | Sep 2025 |
|
| Agf Management | 7.0M | $7.9M | 100% | Dec 2025 |
|
| Readystate Asset Management | 7.0M | $7.9M | 100% | Dec 2025 |
|
| Ameriprise Financial | 7.0M | $7.9M | 100% | Dec 2025 |
|
| Lazard Asset Management | 5.5M | $62k | -57% | Dec 2025 |
|
| SSI Investment Management | 5.5M | $6.2M | 0% | Dec 2025 |
|
| Calamos Advisors | 5.0M | $5.6M | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 4.1M | $4.0M | 100% | Sep 2025 |
|
| Bnp Paribas Investment Partners | 2.5M | $2.8M | 0% | Dec 2025 |
|
| Palisade Capital Management | 2.0M | $2.0M | 0% | Sep 2025 |
|
| RWC Asset Management | 1.5M | $1.7M | 100% | Dec 2025 |
|
| New York State Common Retirement Fund | 1.3M | $1.5M | -53% | Dec 2025 |
|
| Barclays | 1.0M | $1.1M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 950k | $1.1M | -34% | Dec 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 600k | $681k | 0% | Dec 2025 |
|
| Sei Investments | 361k | $405k | 33% | Dec 2025 |
|
| Bank of New York Mellon | 200k | $225k | 0% | Dec 2025 |
|
| Insigneo Advisory Services | 16k | $18k | 0% | Dec 2025 |
|
| Wealth Enhancement Advisory Services | 12k | $13k | 0% | Dec 2025 |
|
| SG Americas Securities | 10k | $1.1M | 0% | Dec 2025 |
|
Who sold out of Bridgebio Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Camden Asset Management | Sep 2025 | 34M | $34B |
| Steelhead Partners | Sep 2025 | 30M | $30B |
| Jump Financial | Sep 2025 | 28M | $28M |
| Millennium Management | Jun 2025 | 5.0M | $4.7M |
| Bnp Paribas Arbitrage, Snc | Sep 2025 | 1.7M | $1.6M |
| Russell Investments | Sep 2025 | 1.7M | $1.6M |
| Toronto-Dominion Bank | Jun 2025 | 1.2M | $1.1M |
| UBS Group | Sep 2025 | 750k | $738k |
| ADAR1 Capital Management | Sep 2025 | 45k | $4.4M |